Switch View
© Globe Newswire
20.08.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
337,000 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 20 AUGUST 2025 at 9.00 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
Heidelberg University Hospital expands its particle therapy program with IBA’s Proteus®ONE solution
News Preview
Louvain-La-Neuve, Belgium, August 20, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer and Heidelberg University Hospital (Universitätsklinikum Heidelberg AöR, UKHD) announce today that they have signed a co...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
20.08.2025
ISIN: CA0909741062
BioNxt Solutions Inc.
BNXT
LISTED
CSE
BioNxt Fast-Tracks U.S. Patent for MS Drug and Secures Broad Platform IP Covering Autoimmune Neurology Pipeline
News Preview
VANCOUVER, BC / ACCESS Newswire / August 20, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in innovative drug delivery technologies, is pleased to announce two key milestones in the expansion and protection of its proprietary drug delivery platform...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
20.08.2025
ISIN: KYG7S12M1051
XtalPi Holdings Limited
2228
LISTED
HKSE
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
News Preview
CAMBRIDGE, Mass., Aug. 20, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
20.08.2025
ISIN: KYG7S12M1051
XtalPi Holdings Limited
2228
LISTED
HKSE
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
News Preview
CAMBRIDGE, Mass., Aug. 19, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
20.08.2025
ISIN: US03476V1008
Angle plc
ANPCY
LISTED
OTC
ANGLE Announces Collaboration with Myriad Genetics
News Preview
Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing tissue-based diagnostic test GUILDFORD, SURREY / ACCESS Newswire / August 20, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in resear...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: KYG4672N1198
HUTCHMED (China) Ltd
13
LISTED
HKSE
HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China
News Preview
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces the completion of patient enrollment of SANOVO, a China Phase III study of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) as a first-line treatment in certain non-small cell lung c...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US62856X2018
TNF Pharmaceuticals, Inc.
TNFA
LISTED
NASDAQ
TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation
News Preview
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that is has significantly improved its financial position over the past 5 months through a material reduction in liabilities, while maintai...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: CH0432492467
Alcon AG
ALC
LISTED
NYSE
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical
News Preview
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and six month periods ending June 30, 2025. For the second quarter of 2025, sales were $2.6 billion, up 4% on a reported basis and up 3% on a constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted earnin...
Themefolio
Profiler
Peergroup
© Newsfile
19.08.2025
ISIN: US45333F1093
Incannex Healthcare Inc
IXHL
LISTED
NASDAQ
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update
News Preview
Dallas, Texas--(Newsfile Corp. - August 19, 2025) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). Recently, IXHL has made significant progress on its IHL-42X asset after very positive topline results from the Phase 2 study have returned, with more granular...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US28176E1082
Edwards Lifesciences Corp.
EW
LISTED
NYSE
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
News Preview
Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $500 million of Edwards’ common stock. With this transaction, Edwards has repurchased more than $800 million of shares in 2025.
Under the terms of this ASR, Edwards will receive an initial delivery of approximately...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development
News Preview
SAN DIEGO, Aug. 19, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development. In this role, Mr. Wolff will report directly to President and Chief Executive Officer Brian Blaser, and h...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
19.08.2025
ISIN: US66987P4090
NovaBay Pharmaceuticals, Inc.
NBY
LISTED
XASE
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
News Preview
Investment to support NovaBay’s continued public listing and provide funding for a future strategic transaction Investment to support NovaBay’s continued public listing and provide funding for a future strategic transaction...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US8087571084
Scientific Industries, Inc.
SCND
LISTED
OTC
Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025
News Preview
TORBAL DIVISION SALES UP 11%SECURED $10 MILLION IN STRATEGIC DIVESTURE OF GENIE PRODUCT LINEVIVID AND BIOPROCESSING NEW PRODUCT AI ROADMAP ON TARGET...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US92859E1082
Vivos Therapeutics Inc.
VVOS
LISTED
NASDAQ
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
News Preview
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US50015M1099
Kodiak Sciences Inc
KOD
LISTED
NASDAQ
Kodiak Sciences to Present at American Chemical Society Fall 2025
News Preview
PALO ALTO, Calif., Aug. 19, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that senior management will present the Company's pipeline programs in glaucoma at the American Chemical Soc...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
News Preview
CONSHOHOCKEN, Pa., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that the European Commission (EC) has granted conditional marketing authorization for Rezdiffra (resme...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US15117B1035
Celldex Therapeutics, Inc.
CLDX
LISTED
NASDAQ
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE)
News Preview
HAMPTON, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported topline results from the Company’s ongoing Phase 2 study of barzolvolimab in eosinophilic esophagitis (EoE), a chronic inflammatory disease of the esophagus. Identifying the key drivers of EoE has challenged the field and research has suggeste...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Arcutis to Present at Upcoming Investor Conferences
News Preview
Arcutis today announced that management will participate in three upcoming investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US53220K5048
Ligand Pharmaceuticals Inc
LGND
LISTED
NASDAQ
Ligand to Participate in September Investor Conferences
News Preview
Ligand to Participate in September Investor Conferences...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15, 2025 it granted stock options to purchase an aggregate of 105,169 shares of common stock and 70,879 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 46 employees, w...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
News Preview
Agreement for Up to $50 Million in Financing. Includes $36 million line of credit and potential $14 million private placement....
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Corporation (NEOG) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
Shareholders with losses of $100,000 or more are encouraged to contact the firm.
BENSALEM, Pa., Aug. 19, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG)....
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Aug. 19, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN).
IF YOU SUFFERED A LOSS ON YOUR BIOHAVEN INVESTMENTS, CLICK HERE BEFORE SEPTEMBER 12, 2025 (LEAD PLAINT...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US58403T1079
MedX Holdings, Inc.
MEDH
LISTED
OTC
MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: We’re at an Inflection Point
News Preview
Sales up; on track for ~$1.5M FY25 revenue. Las Vegas lounge approaching approvals. Leaf-trak POS rolling out Q3. Pipeline building in Florida and California. Sales up; on track for ~$1.5M FY25 revenue. Las Vegas lounge approaching approvals. Leaf-trak POS rolling out Q3. Pipeline building in Florida and California....
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Securities Fraud Investigation Into Nutex Health Inc. (NUTX) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: US0010041004
ADM Tronics Unlimited, Inc.
ADMT
LISTED
OTC
ADM Tronics Reports First Quarter of Fiscal Year 2026 Results
News Preview
NORTHVALE, NJ / ACCESS Newswire / August 19, 2025 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its first fiscal quarter ended June 30, 2025 of Fiscal Year 2025.The upward trend in revenues, as reported in the Company's Annual 10-K Report for...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders
News Preview
Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to registerAs announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inc...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: KYG4783B1032
Innocare Pharma Limited
9969
LISTED
HKSE
InnoCare Releases 2025 Interim Results and Business Highlights
News Preview
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2025 interim results as of 30 June 2025.
Significant Revenue Growth from Orelabrutinib
Total Revenue of InnoCare increased by 74.3% year-on-year (YoY) to RMB731.4 million1 for the six months ended 30 J...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
News Preview
WARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN) announced its financial results for the fiscal quarter ended June 30, 2025, and filed its Form 10-Q with the Securities and Exchange Commission (“SEC”), highlighting improved operational efficiency....
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: SE0009973563
XSpray Pharma AB (publ)
XSPRAY
LISTED
STO
Xspray Pharma Submits XS003 to the FDA – The Company’s Second Product Candidate from the HyNap Platform
News Preview
Xspray Pharma (Nasdaq Stockholm: XSPRAY) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate XS003 (nilotinib) for the treatment of chronic myeloid leukemia (CML). The application is based on successful studies demonstrating bioequivalence with the reference product Tasigna®. XS003 de...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2025
News Preview
...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US30048L3024
Evofem Biosciences, Inc
EVFM
LISTED
OTC
FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis
News Preview
-- Evofem now holds eleven Orange Book - listed patents covering SOLOSEC into late 2041 --
SAN DIEGO, Aug. 19, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCID: EVFM) today announced that a newly-issued U.S. patent which covers SOLOSEC® (secnidazole) 2 g oral granules and one of its labeled indications is now listed in the U.S. Food and Drug...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US92556V1061
Viatris Inc
VTRS
LISTED
NASDAQ
Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer
News Preview
PITTSBURGH, Aug. 19, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced the appointment of Andrew Enrietti as Chief Administrative and Transformation Officer. In this newly created role, Enrietti will oversee the company's Human Relations, Business Transformation, Information Technology, Information Sec...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US88025U1097
10X Genomics Inc
TXG
LISTED
NASDAQ
10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis
News Preview
First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology
PLEASANTON, Calif., Aug. 19, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Xenium Prote...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US40171F5017
Guided Therapeutics, Inc.
GTHP
LISTED
OTC
Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings
News Preview
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that on August 14th 2025, it had received a payment of $70,000 from its new distribution partner in China, Hangzhou Dongye Medical Technology Company, Ltd. (HDMT). This is the second scheduled payment in a series of nine payments that will total $700...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 18 August 2025 was 348.35p (cum income). ...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Completes Acquisition of Capstan Therapeutics
News Preview
Acquisition adds a potential first-in-class in vivo targeted lipid nanoparticle (tLNP) anti-CD19 CAR-T therapy candidate for B cell-mediated autoimmune diseases as well as a proprietary tLNP platform designed to deliver RNA payloads, such as mRNA, capable of engineering specific cell types in vivoNORTH CHICAGO, Ill., Aug. 19, 2025 /PRNewswire/ --...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Shareholders that lost money on Altimmune, Inc.(ALT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recov...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Capricor Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit se...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to reco...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to re...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Class Action Filed Against Replimune Group, Inc. (REPL) - September 22, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit.
CLASS DEFINITION: The law...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 19, 2025 to Discuss Your Rights - ANRO
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. ("Alto Neuroscience, Inc." or the "Company") (NYSE: ANRO) of a class action securities lawsuit.
CLASS DEFINITION: The l...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Shareholders of Neogen Corporation Should Contact Levi & Korsinsky Before September 16, 2025 to Discuss Your Rights - NEOG
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Neogen Corporation ("Neogen Corporation" or the "Company") (NASDAQ: NEOG) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit s...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Centene Corporation(CNC) Shareholders
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recov...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
Shareholders that lost money on Sarepta Therapeutics, Inc.(SRPT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seek...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - August 25, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.
CLASS DEFINIT...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: KYG970081173
WuXi Biologics (Cayman) Inc
2269
LISTED
HKSE
WuXi Biologics Reports Solid 2025 Interim Results
News Preview
Revenue increased by 16.1% YoY to RMB 9,953.2 million; revenue growth from continuing operations was 20.2%IFRS Gross profit margin expanded by 3.6% YoY to 42.7%EBITDA grew 50.5% YoY and IFRS net profit increased 54.8% YoYAdjusted EBITDA grew 20.6% YoY and adjusted net profit increased 11.6% YoYFY25 group revenue growth target raised to 14% – 16%A...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: US13765D1090
CannaPharmaRX, Inc.
CPMD
LISTED
OTC
CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue
News Preview
CREMONA, AB / ACCESS Newswire / August 19, 2025 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an emerging leader in global cannabis cultivation and exports, announces a series of strategic developments. The goal is to strengthen its international footprint and production capacity.The company continues to make significant steps in its mission to supply pre...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US45256X1037
Immunitybio Inc
IBRX
LISTED
NASDAQ
ImmunityBio Announces Phase 2 Study of ANKTIVA® in Patients with Long COVID
News Preview
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the opening of a new Phase 2 study to assess the BioShield™ platform, anchored by ANKTIVA® (nogapendekin alfa inbakicept-pmln), in patients with long COVID. An estimated one in five Americans with a previous COVID-19 infection has long COVID, which is comprised of a...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US24661P8077
Delcath Systems, Inc.
DCTH
LISTED
NASDAQ
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
News Preview
Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the first patient has been dosed at the City of Hope National Medical Center in its global Phase 2 Clinical Trial evaluating HEPZATO™ in combination with standard of care (SOC) treatment fo...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US1241551027
Butterfly Network Inc
BFLY
LISTED
NYSE
Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa
News Preview
Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced its role in the international research study CAD LUS4TB that will evaluate the impact of AI-assisted point-of-care ultrasound (POCUS) on tuberculosis (TB) triage in under-resourced sett...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US69366J2006
PTC Therapeutics Inc
PTCT
LISTED
NASDAQ
PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA
News Preview
WARREN, N.J., Aug. 19, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) related to the New Drug Application (NDA) for vatiquinone for the treatment of children and adults living with Friedreich's ataxia.
"We are of course disapp...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
SkinMedica® Unveils Its Newest Hydration Hero
News Preview
By the makers of BOTOX® Cosmetic (onabotulinumtoxinA), SkinMedica® introduces a next generation amino acid–based cleanser: HA5® Hydra Collagen Hydrating Foaming Cleanser.IRVINE, Calif, Aug. 19, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today the newest addition to the SkinMedica® HA5® Hydra Collagen portf...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity, in the life sciences segment of the health care sector, today launched the Twist Oncology DNA Comprehensive Genomic Profiling (CGP) Panel, a customizable, research-use-only solution designed to empower users to identify genomic alterations for a broad set of tumor...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US74765K1051
Quantum-Si Inc
QSI
LISTED
NASDAQ
Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will be participating in the H.C. Wainwright 27th Annual Global Investment Conference taking place at the Lotte New York Palace Hotel, September 8-10, 2...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Annual Humana Community Day Expands Nationwide to Deepen Employee Impact in Local Communities
News Preview
Humana Inc. (NYSE: HUM) will host its second annual Humana Community Day, on Thursday, Sept. 4, bringing thousands of employees together in a coordinated day of service across the country. This initiative, part of Humana’s Community Impact programming, aims to foster a sense of belonging among employees while delivering meaningful support in the c...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US5747951003
Masimo Corporation
MASI
LISTED
NASDAQ
Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters
News Preview
Masimo (NASDAQ: MASI) today announced the FDA 510(k) clearance of expanded indications for the delta hemoglobin parameters provided with O3® Regional Oximetry. The parameters (ΔcHb, ΔHHb, and ΔO2Hb) display relative changes in hemoglobin that can help clinicians identify the underlying mechanisms responsible for changes in tissue oxygen saturation...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte to Present at Upcoming Investor Conferences
News Preview
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of September:
Cantor Global Healthcare Conference on Wednesday, September 3, 2025 at 8:00 am (EDT)
Well Fargo Healthcare Conference on Thursday, September 4, 2025 at 8:45 am (EDT)
Morgan Stanley 23rd Annual Global Healthcare Co...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
